Skip to main content
Guidance

Biocide changes: preparing your business

Find out how biocide rules will change under the SPS Agreement

The UK and EU have agreed to align on sanitary and phytosanitary (SPS) rules. This will affect rules for food and feed, plants, animals and other agrifood goods.

Find out more about the agreement and its impact.

The new UK-EU Sanitary and Phytosanitary Agreement will change how biocides are regulated, marketed and used in Great Britain.

The agreement delivers closer alignment between Great Britain and EU rules covering active substance decisions and biocidal product authorisations.

From the agreement’s application date, 1 March 2028, Great Britain will follow EU Biocidal Products Regulation No 528/2012 (EU BPR).

This guidance is intended to help businesses prepare for implementation of the SPS Agreement. Details remain subject to legislative processes.

Read more about the SPS Agreement and how it might impact your business.

Who should read this guidance

This guidance applies to all businesses involved in the manufacture, processing, distribution, supply, marketing or use of biocidal active substances, biocidal products and treated articles, placed on the Great Britain market, including:

  • active substance manufacturers
  • biocidal product manufacturers
  • biocidal product authorisation holders
  • biocidal product COPR approval holders
  • formulators and processors
  • importers and exporters
  • distributors and wholesalers
  • retailers
  • users of biocidal products
  • operators placing treated articles on the market

Overview of what’s changing

From 1 March 2028, Great Britain will operate a regulatory system for biocides that is aligned with the EU. All areas across the regime will be covered by a single framework with incorporated transitional measures, including:

  • active substance approval status
  • biocidal product authorisations
  • transitional arrangements for existing stocks, supply and use

The EU BPR, and all its supplementary EU regulations and EU implementing decisions, will apply in Great Britain, including decisions made in relation to active substance approvals and product authorisations.

Ministerial decisions taken in accordance with Great Britain Biocidal Products Regulation (GB BPR) will no longer be applicable. Ministerial decisions taken under GB BPR (HSE website).

Likewise, any guidance published by the EU that is not already adopted in Great Britain will become relevant. Existing published GB BPR specific guidance (HSE website) will no longer be applicable.

We are considering the appropriate handling of new and ongoing applications as Great Britain transitions towards the SPS Agreement taking effect. Options being considered include amending or stopping work on Great Britain applications that may not be compatible with the EU biocides regime, and accepting applications compatible with the EU regime before the application date. HSE intends to legislate in this area to provide for early alignment with the EU regime, however, the details of these measures remain subject to legislative processes. Further information will be communicated in due course on the HSE biocides webpages.

Active substance approval status

The status of all biocide active substances in the EU will become the current status in Great Britain. For example, if an active substance is approved in the EU but currently under review in Great Britain, on 1 March 2028, it will become approved in Great Britain.

From 1 March 2028, approval of active substances will operate under the EU regulatory framework. Great Britain will no longer operate a separate approval system, or review programme for active substances. Businesses seeking approval of active substances should engage with the EU application process.

The United Kingdom will have a role, in accordance with the terms of the agreement, in the EU decision-shaping process, and act as an evaluating competent authority/member state for active substances and Union authorisations. This will help to ensure that EU decision making takes into account UK considerations, such as environmental, social and economic conditions.

Biocidal product authorisations

The agreement requires HSE to check that all current Great Britain biocidal product authorisations issued before 1 March 2028 comply with the requirements laid down in Article 19 or, for products eligible for the simplified procedure, Article 25 of EU BPR. Where they do not comply, prompt action will be taken to change these authorisations so they comply with EU requirements, or cancel them if necessary. This is further explained in the section GB authorised products that do not comply with EU regulatory requirements.

Union authorisations granted by the EU will become valid in Great Britain. Any exemptions to this will be communicated by HSE at a later date.

Contact from HSE

Before 1 March 2028, HSE will contact all BPR authorisation holders and applicants confirming any impacts on their BPR authorisation or application.

In addition, HSE will contact all Control of Pesticides Regulations (COPR) approval holders confirming any impacts on their COPR approval.

If you have not heard from us before 1 March 2028 you should email HSE at biocidesenquiries@hse.gov.uk.

EU CLP and REACH regulations

Along with EU BPR applying, biocidal products and active substances will need to comply with EU classification, labelling and packaging (EU CLP) (Regulation (EC) No 1272/2008 (EUR-Lex)), including any EU harmonised classification and labelling requirements.

Biocidal products and active substances will also need to comply with any applicable requirements in the EU Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) Regulation (Regulation (EC) No 1907/2006 (EUR-Lex)) such as the requirement to prepare and make available Safety Data Sheets.

Further guidance on the applicability of these will be provided at a later date on the HSE biocides webpages.

Overview: what happens when

Before 1 March 2028

Biocidal active substance and product manufacturers should ensure they understand the incoming EU BPR status of any relevant active substances.

To support this, HSE will monitor developments in the EU and maintain publicly available up-to-date lists of substances. HSE will also publish guidance and ebulletins on a regular basis.

We will contact authorisation holders, applicants, COPR approval holders, active substance supporters/applicants and Article 95 suppliers. – Email HSE at biocidesapplications@hse.gov.uk if your contact details have changed.

Stakeholders should remain aware of the status of active substances and understand the implications of any changes.

On SPS Agreement application date – 1 March 2028

From this date, all relevant EU rules and decisions will apply. Where transitional measures are required, they will begin on this date. For example, products may need to be withdrawn from the market following a change in the status of the active substance they contain, and phase-out periods will apply to them.

After SPS application date

The impact of any transitional periods will vary depending on the active substances contained in a product, as well as the actions taken by manufacturers and suppliers, and HSE. It is important that stakeholders keep up to date with information provided through HSE ebulletins and guidance published on the HSE website.

Key situational changes and timeframes

The situations described below are likely to affect the greatest number of stakeholders. They summarise the transitional provisions set out in the agreement, but they do not cover all possible status changes and scenarios. Read more detailed scenario guidance on the HSE website.

Note that the phase-out periods and periods of grace shown are those specified in the agreement and may differ from the standard periods of grace provided under the BPR. Where affected products hold a COPR approval or BPR authorisation, the applicable phase-out periods or periods of grace will be set out in the certificates issued by HSE.

The SPS application date is the starting point for the transitional provisions and timeframes detailed below.

Situation 1: Active substance not allowed in biocidal products on the EU market on 1 March 2028, where it was allowed in Great Britain before application date.

For example, due to an EU non-approval decision

What changes and what you need to do:

  • remove biocidal products from the Great Britain market
  • manage your supply chains including informing downstream suppliers and where possible users of applicable dates

Timeframe:

  • non-approval decision applies in Great Britain from 1 March 2028
  • biocidal products can be made available on the Great Britain market until 31 May 2028, and be used until 30 November 2028.

Other examples are described in the more detailed scenario guidance on the HSE website.

Situation 2: Active substance is approved for use in biocidal products in the EU on 1 March 2028, where it was still being evaluated in Great Britain before application date.

For example, it was still under-review in Great Britain.

What changes and what you need to do:

  • begin to assemble a product authorisation data dossier for submission
  • submit product authorisation application for Great Britain market (where all active substances in the biocidal products are approved)
  • look out for HSE communications to explain this application process.

Timeframe:

  • submit product authorisation applications on or before 31 August 2028, to maintain existing market access through transitional measures
  • if no application is received on time, biocidal products may continue to be made available on the Great Britain market until 28 February 2029, and used until 31 August 2029

Other examples are described in the more detailed scenario guidance on the HSE website.

Situation 3: Active substance is permitted in biocidal products on the EU market before 1 March 2028, but was not permitted in biocidal products on the Great Britain market.

For example, it is in the EU review programme on 1 March 2028, but has received a GB BPR non-approval decision.

What changes and what you need to do:

  • products can access the Great Britain market. You need to ensure your product is compliant with existing national rules
  • if the product is within scope of COPR you may need to apply or re-apply for COPR approval. Look out for HSE communications to explain this application process

Timeframe:

  • market access can begin from 1 March 2028, subject to any necessary approvals, such as COPR
  • where a COPR approval is required any application deadlines or timeframes will be provided by HSE in due course

Other examples are described in the more detailed scenario guidance on the HSE website,

Situation 4: The active substance is approved for use in biocidal products in both EU and Great Britain, but the approval conditions are different in the EU compared to Great Britain.

For example, where an active substance approval has been renewed and the approval conditions have changed.

What changes and what you need to do:

  • be aware of how changes to the active substance approval can impact your product
  • if you have a Great Britain product authorisation it may need changing or cancelling
  • if you do not yet have a product authorisation, your product label or use instructions may need to be changed or your product may need to be removed from the market
  • look out for HSE communications to explain any actions you may need to take

Timeframe:

  • there will be a 3-month window following the SPS application date for HSE to check and change or cancel product authorisations to ensure compliance with EU BPR requirements
  • existing stocks that do not meet EU requirements can be made available on the Great Britain market until 30 November 2028 and used until 30 June 2029

Other examples are described in the more detailed scenario guidance on the HSE website.

Situation 5: Treated articles (articles treated with biocidal products) either containing an active substance that is not approved in the EU, or that do not comply with the conditions or restrictions set out in the approval of the active substances concerned.

What changes and what you need to do:

  • if the active substance used is not allowed in treated articles in the EU then you will have to stop placing these on the market in Great Britain
  • if the active substance used is permitted in treated articles on the EU market, from 1 March 2028, you should begin to comply with any EU restrictions or labelling requirements

Timeframe:

  • from 1 March 2028, EU BPR rules and requirements apply
  • treated articles not complying with EU BPR may continue to be placed on the market until 31 August 2028

Additional information can be found, and other examples are described, in the more detailed scenario guidance on the HSE website.

Impact on active substances

Active substances in Great Britain will adopt the corresponding EU status from SPS application date.

For many active substances, there will be no change. For others, the status may remain the same, but the expiry date may change.

However, some active substances will have a change in status. This means that active substances that are currently under review or assessment in Great Britain may become approved or not approved. Active substances that are currently not approved or whose approval has expired in Great Britain may become approved, approved under renewal or under review. Similarly, active substances that are currently approved in Great Britain may become expired or cancelled.

Article 95 requirements (HSE website) (the list of acceptable active substance suppliers) for active substances will also be affected. From 1 March 2028, the EU Article 95 list will apply in Great Britain, and products supplied in Great Britain will need to ensure that their active substances are sourced from suppliers included on the EU Article 95 list. Suppliers currently listed on the GB Article 95 list and who are not on the EU Article 95 list will need to be included on the EU Article 95 list. Further guidance on this will be provided when available on the HSE biocides webpages, but you can also read European Chemicals Agency (ECHA) guidance on Article 95. Stakeholders should be aware there is no additional transitional period for this, compliance with Article 95 should be achieved by SPS application date.

Technical equivalence decisions made in Great Britain will no longer be valid. From 1 March 2028, technical equivalence decisions taken by the EU will become relevant in Great Britain. Biocidal products authorised in Great Britain will need to ensure that their active substance manufacturing source has been assessed and concluded to be technically equivalent by ECHA.

Impact on biocidal products – for manufacturers and authorisation holders

HSE will continue to act as the competent authority for biocides, including granting biocidal product authorisations for the Great Britain and Northern Ireland markets. Additional application routes will become available after 1 March 2028, for example mutual recognition and simplified notifications.

The regulatory outcome for a biocidal product will depend on the EU approval status of the active substances it contains. For example, some products that do not yet require a GB BPR authorisation, including some that may hold a COPR approval, may be required to submit a BPR application after 1 March 2028, whilst others may need to be withdrawn from the market, subject to an applicable phase-out period.

The situational changes section provides a summary of the key changes/impacts, but given the range of possible scenarios, HSE will publish further guidance on its website outlining the regulatory requirements associated with each scenario.

Biocidal product manufacturers should regularly monitor the status of the active substances contained in their products, as these statuses may change before 1 March 2028. You can monitor the active substance status by subscribing to HSE biocide ebulletins, checking the HSE list of active substances, or checking the new HSE SPS List of Active Substances .

Products currently authorised under GB BPR for which the active substance status will not change on 1 March 2028, may continue to be made available on the Great Britain market until the end of their authorisation period. However, in line with existing practice, they should not be supplied or moved into the EU market unless they have a specific EU BPR authorisation (and comply with the terms and conditions of that EU BPR authorisation). Any subsequent renewals of these authorisations will be processed under EU BPR. Renewal applications for authorisations granted by Great Britain before 1 March 2028, will need to be submitted to Great Britain for evaluation.

Great Britain authorised products that do not comply with EU regulatory requirements

HSE will carry out a compliance check of products on the market to ensure that they comply with EU regulatory requirements.

Where authorisations do not comply with the relevant requirements in the EU, they will be changed, or where this is not possible, cancelled, in accordance with the transitional arrangements agreed. HSE will contact the authorisation holder regarding the required changes by 1 March 2028.

Any existing stock that does not meet the new conditions and restrictions of the authorisation will need to be removed from the market in line with any relevant phase-out periods. The exact dates will be provided in your new certificate.

Where the non-compliance cannot be resolved and results in the cancellation of the authorisation, the relevant phase-out periods will apply and will be detailed in your new certificate.

From 1 March 2028, EU CLP will apply to biocidal products authorised under BPR. More information on the application of EU CLP to biocides and its implications for biocidal product manufacturers and suppliers will be provided at a later date on the HSE biocides webpages.

Products with a Union authorisation (or pending Union authorisation)

EU decisions on existing and future Union authorisations will apply in Great Britain. Products that currently hold a Union authorisation granted under EU BPR will be permitted on the Great Britain market from 1 March 2028. Any exemptions to this will be communicated by HSE at a later date. ECHA guidance on Union authorisation.

Similarly, product manufacturers in Great Britain will have the opportunity to access the EU market through Union authorisations, which may be a preferred route for some companies.

Product applicants in Great Britain that already hold a Union authorisation or pending Union applications should email HSE at <biocidesenquiries@hse.gov.uk?subject=SPS%20business%20readiness%20enquiry> to ensure that the same product does not have two concurrent applications/authorisations.

Future BPR product authorisations using mutual recognition process

Once EU BPR applies in Great Britain (from 1 March 2028), it will also be possible to obtain product authorisations in Great Britain through the mutual recognition process. For new applications submitted after 1 March 2028, HSE as the Great Britain competent authority can act as both a reference member state or a concerned member state. This means for new applications you can seek mutual recognition from Great Britain into the EU or into Great Britain from the EU. ECHA guidance on mutual recognition.

Applicants, specifically those with applications already submitted to Great Britain, and where the product is already authorised in an EU member state, may seek authorisation in Great Britain through mutual recognition in sequence.

Mutual recognition in parallel will also be available under the new framework.

Guidance about the mutual recognition application process in Great Britain/UK will be provided at a later date, on the HSE biocides webpages.

Existing Great Britain authorisations granted before the SPS application date cannot be mutually recognised in the EU.

Impact on biocidal products – for suppliers, retailers and users

It is important to note that some products will need to be withdrawn from the market. Suppliers and retailers should therefore regularly check the product authorisation/approval status and be aware of any forthcoming market withdrawals. You can check the regulatory status and relevant expiry dates of a biocidal product on the HSE UK authorised biocidal products list and the HSE COPR approved biocidal products list.

Suppliers should check the making available on the market expiry date, which is the date after which the product can no longer be supplied.

Users should check the use and disposal expiry date, which is the date after which the product must no longer be used and should be disposed of safely in accordance with local regulations. If you are unsure whether a product can still be used, contact your supplier, professional adviser, or the company named on the product label to confirm its status and applicable dates.

Please note that there may be time delays in updating these HSE lists from when decisions are taken. Up to date information will be available from the product manufacturer or authorisation/approval holder.

Users of biocidal products can also find additional information relating to the safe use of biocides on the HSE website.

If you are aware of any disproportionate negative impacts that are likely to arise from the removal of a product, email HSE at biocidesenquiries@hse.gov.uk.

Impact on treated articles

The regulation of treated articles is not changing. HSE guidance on treated articles.

However, as the availability of treated articles is linked to the status of the active substance they are treated with, and active substances in Great Britain will adopt the corresponding EU status on 1 March 2028, there may be changes as a result of the agreement.

From 1 March 2028, if you place a treated article on the Great Britain market you will need to check if the active substance in the biocidal product used to treat the article is still acceptable – currently you can use the ‘Can be used in treated articles’ column on the EU tab of the HSE list of active substances. You can also check the allowed active substances in treated articles (Article 94 list) published by ECHA.

You should also check if the active substance is approved for the relevant product type and use in the EU or is included in Annex I of EU BPR (simplified active substance). You will also need to check if the approval contains specific restrictions or requirements for placing treated articles on the market for the relevant product type. You can check this on the EU tab of the HSE list of active substances, or ECHA’s information on biocides.

What this means for Northern Ireland

In accordance with the Windsor Framework, Northern Ireland continues to apply EU BPR, covering rules on biocidal products and active substances.

As a result, the arrangements set out in this guidance apply to Great Britain only and do not alter regulatory requirements in Northern Ireland.

Compliance and enforcement

There are no changes to the rules governing compliance of biocidal products and active substances. Failure to comply with your duties under the laws that control biocides in the UK may be considered an offence. This covers both GB BPR before SPS application date and EU BPR after 1 March 2028. There is further guidance on enforcement on the HSE website.

Record keeping duties also remain the same under both GB BPR before SPS application date and EU BPR after 1 March 2028. HSE guidance on record keeping.

In line with existing practice, biocidal products must not be supplied or moved into the EU market unless they have a specific EU BPR authorisation (and comply with the terms and conditions of that EU BPR authorisation).

In addition, treated articles must not be moved into the EU market unless any active substances in the biocidal products used to treat it are approved for that use in the EU and that any conditions or restrictions associated with the EU’s approval are met. The person responsible for placing any treated article on the market must label it with any relevant instructions for use, including any precautions to be taken, if this is necessary to protect humans, animals and the environment. This should include any instructions or restrictions relevant to the conditions under which the active substance is approved in the EU.

What you can do to prepare

Find out what support will be available for businesses to help you prepare for the changes.

Whatever your role is relating to biocides you should ensure you understand the new status of any relevant active substances and the impact on biocidal products you supply or use.

One way to do this is by comparing the Great Britain and EU active substance status and determining the scenario. We have published a new HSE SPS list of biocide active substances that confirms the current status and provides a scenario for each possible combination. In addition there is HSE guidance on scenario details and implications.

If the status is changing this may impact the supply and use of biocidal products or treated articles. Stakeholders should remain aware of the status of active substances and understand the implications of any changes.

Further guidance and information

Health and Safety Executive (HSE) for biocide specific information such as biocidal product authorisations and active substance status. More specifically the HSE biocides SPS Agreement webpages are where you can find the latest biocide SPS information.

Further guidance will be developed, and targeted communications will be issued as more information becomes available.

Updates from HSE

HSE will contact authorisation holders, applicants, COPR approval holders, active substance supporters/applicants and Article 95 suppliers directly with further details.  Email HSE at biocidesapplications@hse.gov.uk if your contact details have changed.

These letters will outline impacts that we have identified and any actions you may need to take. If you have not heard from us before SPS application date you should email HSE at biocidesenquiries@hse.gov.uk.

HSE will also publish ebulletins on a regular basis to keep affected stakeholders updated. You can subscribe to HSE biocide ebulletins.

You can also:

Technical queries 

Biocide queries regarding the agreement should be sent to the HSE biocides stakeholder advice and support service at biocidesenquiries@hse.gov.uk.

Sign up for emails or print this page